LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Search

Medtronic PLC

Închisă

SectorSănătate

91.97 -0.24

Rezumat

Modificarea prețului

24h

Curent

Minim

91.33

Maxim

92.17

Indicatori cheie

By Trading Economics

Venit

-17M

1B

Vânzări

-349M

8.6B

P/E

Medie Sector

25.425

35.724

EPS

1.26

Randament dividend

3.03

Marjă de profit

12.124

Angajați

95,000

EBITDA

-50M

2.2B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+7.51% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.03%

3.09%

Următoarele câștiguri

18 nov. 2025

Data viitoare de dividende

17 oct. 2025

Următoarea dată ex-dividende

26 sept. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-987M

118B

Deschiderea anterioară

92.21

Închiderea anterioară

91.97

Sentimentul știrilor

By Acuity

49%

51%

170 / 372 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Medtronic PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

19 aug. 2025, 11:39 UTC

Câștiguri

Medtronic Posts Higher 1Q Revenue, Boosts Outlook as Tariffs Ease

21 mai 2025, 11:38 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Medtronic Boosts Dividend, Plans to Separate Diabetes Business and Targets Revenue Growth for Year

19 aug. 2025, 20:33 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

These Stocks Moved the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More -- Barrons.com

19 aug. 2025, 17:41 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 aug. 2025, 13:35 UTC

Acțiuni populare

Stocks to Watch Tuesday: Intel, Medtronic, Home Depot -- WSJ

19 aug. 2025, 12:48 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 aug. 2025, 11:27 UTC

Câștiguri

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 aug. 2025, 10:51 UTC

Câștiguri

Medtronic Sees FY26 Reported Revenue Growth 6.5%-6.8% >MDT

19 aug. 2025, 10:50 UTC

Câștiguri

Medtronic Had Seen FY26 Adjusted EPS $5.50-$5.60 >MDT

19 aug. 2025, 10:50 UTC

Câștiguri

Medtronic Raises FY26 View To Adj EPS $5.60-Adj EPS $5.66 >MDT

19 aug. 2025, 10:50 UTC

Câștiguri

Medtronic Cuts FY26 Potential Tariff Impact View to About $185M From $200M-$350M >MDT

19 aug. 2025, 10:49 UTC

Câștiguri

Medtronic Raises FY26 Adjusted EPS Growth View to About 4.5% From About 4%, Excluding Potential Tariff Impact >MDT

19 aug. 2025, 10:48 UTC

Câștiguri

Medtronic Still Sees FY26 Organic Revenue Up About 5% >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Medical Surgical Portfolio Rev $2.08B >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Cardiovascular Portfolio Rev $3.29B >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Neuroscience Portfolio Rev $2.42B >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Organic Revenue Up 4.8% >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q EPS 81c >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Net $1.04B >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Diabetes Rev $721M >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Sales $8.58B >MDT

19 aug. 2025, 10:45 UTC

Câștiguri

Medtronic 1Q Adj EPS $1.26 >MDT

19 aug. 2025, 09:12 UTC

Acțiuni populare

Stocks to Watch Tuesday: Intel, Palo Alto, Tegna, Home Depot -- WSJ

12 iun. 2025, 13:01 UTC

Achiziții, Fuziuni, Preluări

Medtronic Targeting Completion of Planned Separation Within 18 Mos of Initial Announcement >MDT

21 mai 2025, 17:23 UTC

Top știri
Achiziții, Fuziuni, Preluări

Medtronic to Separate Diabetes Business as Stand-Alone Company -- 2nd Update

21 mai 2025, 11:39 UTC

Top știri
Achiziții, Fuziuni, Preluări

Medtronic to Separate Diabetes Business as Stand-Alone Company -- Update

21 mai 2025, 10:52 UTC

Câștiguri

Medtronic Sees FY26 Adjusted EPS Up About 4% Excluding Potential Impacts From Increased Tariffs >MDT

21 mai 2025, 10:51 UTC

Câștiguri

Medtronic Sees FY26 Adj EPS $5.50-Adj EPS $5.60, Including Potential Tariff Impact >MDT

21 mai 2025, 10:50 UTC

Câștiguri

Medtronic Sees FY26 Reported Revenue Up 4.8%-5.1% if Recent Forex Rates Hold >MDT

21 mai 2025, 10:49 UTC

Câștiguri

Medtronic Sees FY26 Organic Revenue Growth Up About 5% >MDT

Comparație

Modificare preț

Medtronic PLC Așteptări

Obiectiv de preț

By TipRanks

7.51% sus

Prognoză pe 12 luni

Medie 99.1 USD  7.51%

Maxim 115 USD

Minim 78 USD

În baza a 26 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMedtronic PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

26 ratings

12

Cumpărare

13

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

83.26 / 84.875Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

170 / 372 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.